Mark Barrett is responsible for identifying, leading, and executing global business development and corporate-level strategic initiatives. Mark leads the effort to build upon Genzyme’s long legacy of partnering and acquiring external innovation to expand Genzyme’s portfolio and pipeline. M.B.A., University of California, Berkeley - Walter A. Haas School of Business B.S., Biology, Duke University
Development and delivery of transformative therapies for patients affected by rare and debilitating diseases.